Active, not recruitingNCT07443449
International SBMA Project (KDA)
Studying Kennedy disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Principal Investigator
- Silvia Fenu, MD, M.D. Ph.DFondazione IRCCS Istituto Neurologico Carlo Besta
- Enrollment
- 700 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2024 – 2026
Study locations (1)
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07443449 on ClinicalTrials.govOther trials for Kennedy disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06862596Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular AtrophyMasahisa Katsuno
- RECRUITINGPHASE2NCT06169046A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyGianni Soraru
- RECRUITINGNANCT04944940Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGNANCT03555578Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"Takeda
- RECRUITINGNCT05966038ALS/MND Natural History Study Data RepositoryMassachusetts General Hospital